deltatrials
Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01465100

Liver Cell Transplant for Phenylketonuria

Hepatocyte Transplantation for Phenylketonuria

Sponsor: Ira Fox

Conditions Phenylketonuria
Interventions Hepatocyte Transplant Immunosuppression Liver Biopsy Liver Evaluation Neuro-psychological Assessment Preparative Radiation Therapy Whole body Phe oxidation testing
Updated 19 times since 2017 Last updated: Aug 11, 2023 Started: Oct 12, 2011 Primary completion: Aug 21, 2015 Completion: Jun 17, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study was funded by NIH grant; grant funding ended in June 2023 without enrollment of additional subjects; the only subject enrolled was in 2011.

Other terminated trials from Ira Fox

More terminations from Ira Fox

Listed as NCT01465100, this PHASE1/PHASE2 trial focuses on Phenylketonuria and remains terminated or withdrawn. Sponsored by Ira Fox, it has been updated 19 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~Aug 2019 · 6 months · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Mar 2020 · 6 months · monthly snapshot~Mar 2020 – ~Aug 2020 · 5 months · monthly snapshot~Aug 2020 – ~Dec 2020 · 4 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Feb 2022 · 9 months · monthly snapshot~Feb 2022 – ~Jan 2023 · 11 months · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Sep 2023 · 7 months · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

19 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Sep 2023 — Jul 2024 [monthly]

    Terminated PHASE1_PHASE2

    Status: Recruiting → Terminated

  4. Feb 2023 — Sep 2023 [monthly]

    Recruiting PHASE1_PHASE2

  5. Jan 2023 — Feb 2023 [monthly]

    Recruiting PHASE1_PHASE2

▶ Show 14 earlier versions

  1. Feb 2022 — Jan 2023 [monthly]

    Recruiting PHASE1_PHASE2

  2. May 2021 — Feb 2022 [monthly]

    Recruiting PHASE1_PHASE2

  3. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE1_PHASE2

  4. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE1_PHASE2

  5. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

  6. Aug 2020 — Dec 2020 [monthly]

    Recruiting PHASE1_PHASE2

  7. Mar 2020 — Aug 2020 [monthly]

    Recruiting PHASE1_PHASE2

  8. Sep 2019 — Mar 2020 [monthly]

    Recruiting PHASE1_PHASE2

  9. Aug 2019 — Sep 2019 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting

  10. Feb 2019 — Aug 2019 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    Status: Suspended → Not Yet Recruiting

  11. Jun 2018 — Feb 2019 [monthly]

    Suspended PHASE1_PHASE2

  12. Feb 2018 — Jun 2018 [monthly]

    Suspended PHASE1_PHASE2

  13. Feb 2017 — Feb 2018 [monthly]

    Suspended PHASE1_PHASE2

  14. Jan 2017 — Feb 2017 [monthly]

    Suspended PHASE1_PHASE2

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ira Fox
Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations